Author name: TB Alliance

We’ve seen it before with statistics surrounding HIV/Aids. Now the virus’s deadly twin, tuberculosis, is taking the HIV/Aids onslaught to

Faced with the multitude of problems that result from and contribute to poverty, how can you decide which strategy to

Novel chemotherapeutic drugs are needed to improve tuberculosis (TB) control, especially in the developing world. Given the magnitude of the

In the war against drug-resistant bacteria, physicians finally might start getting some new weapons. Experts have long complained that the

Chemistry gets a boost at the TB Alliance with the arrival of the seasoned medicinal chemist Dr. Takushi Kaneko. Kaneko

The Clinton Global Initiative Annual Meeting convenes a diverse group of approximately 1,000 world leaders to examine today’s most pressing

FOR CENTURIES, tuberculosis took a terrible toll until the advent of effective medicines. The world then grew complacent and let

Adding a new antibiotic to the standard mix of drugs used to treat tuberculosis could shave at least two months

New research gives hope for successfully treating tuberculosis in a few months rather than the six months or more currently

The TB Alliance is launching an innovative approach to accelerating the identification and development of new, optimized, combination drug regimens